|
Name |
1-Ethoxypentane
|
| Molecular Formula | C7H16O | |
| IUPAC Name* |
1-ethoxypentane
|
|
| SMILES |
CCCCCOCC
|
|
| InChI |
InChI=1S/C7H16O/c1-3-5-6-7-8-4-2/h3-7H2,1-2H3
|
|
| InChIKey |
VDMXPMYSWFDBJB-UHFFFAOYSA-N
|
|
| Synonyms |
1-Ethoxypentane; Pentane, 1-ethoxy-; 17952-11-3; Ether, ethyl pentyl; Ethyl pentyl ether; Ethyl amyl ether; Amyl ethyl ether; NSC-152102; Butane, ethoxymethyl-; EINECS 241-877-1; BRN 1731551; 1-ethoxy-pentane; 1-Ethoxypentane #; ethyl 1-pentyl ether; BG9HT4KHP4; 3-01-00-01602 (Beilstein Handbook Reference); n-C5H11OC2H5; SCHEMBL127880; DTXSID90170822; ZINC1555811; NSC152102; STL453700; AKOS006275946; NSC 152102; FT-0607732; Q3591983
|
|
| CAS | 17952-11-3 | |
| PubChem CID | 87370 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 116.2 | ALogp: | 2.6 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 9.2 | Aromatic Rings: | 0 |
| Heavy Atoms: | 8 | QED Weighted: | 0.502 |
| Caco-2 Permeability: | -4.141 | MDCK Permeability: | 0.00003110 |
| Pgp-inhibitor: | 0 | Pgp-substrate: | 0.002 |
| Human Intestinal Absorption (HIA): | 0.001 | 20% Bioavailability (F20%): | 0.012 |
| 30% Bioavailability (F30%): | 0.003 |
| Blood-Brain-Barrier Penetration (BBB): | 0.84 | Plasma Protein Binding (PPB): | 72.76% |
| Volume Distribution (VD): | 1.163 | Fu: | 33.39% |
| CYP1A2-inhibitor: | 0.809 | CYP1A2-substrate: | 0.657 |
| CYP2C19-inhibitor: | 0.189 | CYP2C19-substrate: | 0.791 |
| CYP2C9-inhibitor: | 0.069 | CYP2C9-substrate: | 0.223 |
| CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.131 |
| CYP3A4-inhibitor: | 0.018 | CYP3A4-substrate: | 0.162 |
| Clearance (CL): | 10.696 | Half-life (T1/2): | 0.565 |
| hERG Blockers: | 0.054 | Human Hepatotoxicity (H-HT): | 0.018 |
| Drug-inuced Liver Injury (DILI): | 0.041 | AMES Toxicity: | 0.008 |
| Rat Oral Acute Toxicity: | 0.049 | Maximum Recommended Daily Dose: | 0.016 |
| Skin Sensitization: | 0.45 | Carcinogencity: | 0.374 |
| Eye Corrosion: | 0.742 | Eye Irritation: | 0.95 |
| Respiratory Toxicity: | 0.053 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC000855 | ![]() |
0.613 | D01QLH | ![]() |
0.467 | ||
| ENC000279 | ![]() |
0.475 | D0AY9Q | ![]() |
0.306 | ||
| ENC000854 | ![]() |
0.475 | D05ATI | ![]() |
0.278 | ||
| ENC000897 | ![]() |
0.469 | D0Z5SM | ![]() |
0.246 | ||
| ENC000655 | ![]() |
0.447 | D07SUG | ![]() |
0.234 | ||
| ENC000398 | ![]() |
0.438 | D0Y3KG | ![]() |
0.231 | ||
| ENC001025 | ![]() |
0.438 | D08SJZ | ![]() |
0.228 | ||
| ENC000570 | ![]() |
0.425 | D06ORU | ![]() |
0.217 | ||
| ENC000261 | ![]() |
0.424 | D0O3AB | ![]() |
0.216 | ||
| ENC000726 | ![]() |
0.417 | D08HQK | ![]() |
0.210 | ||